Login / Join

analysis by بورس24 | Bourse24 about Stock دکوثر on 8/29/2022

https://sahmeto.com/message/1425229

✅ Change in the composition of the board of directors Kosar Pharmaceutical Company announced the change of CEO and Mr. Babak Mesbahi's appointment as CEO because of a problem with the Ryan Stock Exchange software. 🔗 Read more ... @Bourse24ir

Translated from: Farsi
Show Original Message
Signal Type: Neutral
Price at Publish Time:
2,620
Share
Signals
Top Traders
Feed
Alerts